Skip to main content
Intermediate Technical IVT

reactive lymphadenopathy

Pronunciation: re-AK-tiv lim-fad-uh-NOP-uh-thee

Enlargement of lymph nodes due to benign inflammatory response rather than malignant involvement.

Full Definition

Reactive lymphadenopathy refers to the enlargement of lymph nodes caused by benign inflammatory or immune responses rather than malignant infiltration. In breast cancer patients, reactive lymphadenopathy can occur in axillary, supraclavicular, or internal mammary lymph nodes due to infection, inflammation, or immune system activation. This condition can complicate staging and treatment planning, as enlarged lymph nodes may mimic metastatic disease on imaging. Tissue sampling through fine needle aspiration or core biopsy may be necessary to distinguish reactive changes from malignant involvement, particularly when lymph node enlargement is the only concerning finding.

Usage

Usage note: Specify location and any clinical context that may explain the reactive changes.

In Context

  • "Axillary ultrasound showed enlarged lymph nodes consistent with reactive lymphadenopathy rather than metastatic disease." — Radiology report
  • "Fine needle aspiration confirmed reactive lymphadenopathy with no evidence of malignant cells." — Cytology report

Also known as

benign lymphadenopathy inflammatory lymphadenopathy

Contrasted with

malignant lymphadenopathy metastatic nodes

Don't confuse with

lymph node metastasis lymphoma

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON